Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Blaser, M. J. (1997). Not all Helicobacter pylori strains are created equal: should all be eliminated? Lancet 349: 1020–1022.
Blaser, M. J., Perez-Perez, G. I. & Kleanthous, H. (1995). Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55: 2111–2115.
Crespi, M. & Citarda, F. (1996). Helicobacter pylori and gastric cancer: an overrated risk? Scand J Gastroenterol 31: 1041–1046.
Danesh, J. (1999). Is Helicobacter pylori a cause of gastric neoplasia? In Infections and Cancer, Beral V, Newton R and Weiss R (eds). Cold Springs Harbor Press: New York. In Press
Danesh, J. (1999). Helicobacter pylori and gastric cancer: systematic review of the epidemiological evidence. Aliment Pharm Ther. In Press
Danesh, J., Forman, D., Collins, R. & Peto, R. (1996). Helicobacter pylori screening and gastric cancer. Lancet 348: 758–759.
Danesh, J., Collins, R. & Peto, R. (1997a). Chronic infections and coronary heart disease: is there a link? Lancet 350: 430–436.
Danesh, J., Newton, R. & Beral, V. (1997b). A human germ project? Nature 389: 21–24.
Forman, D. (1988). Lessons from ongoing intervention studies. In Helicobacter pylori: Basic Mechanisms to Clinical Cure, Hunt R,Tytgat G (eds) Kluwer: Amsterdam
Goodwin, C. S., Mendall, M. M. & Northfield, T. C. (1997). Helicobacter pylori infection. Lancet 349: 265–269.
Halpern, M. T., Gillespie, B. W. & Warner, K. E. (1993). Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst 85: 457–464.
Hansson, L. E., Nyren, O., Hsing, A. W., Bergstrom, R., Josefsson, S., Chow, W. H., Fraumeni, J. F. & Adami, H. O. (1996). The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 335: 242–249.
Howson, C. P., Hiyama, T. & Wynder, E. L. (1986). The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 8: 1–27.
Hsieh, L. L., Lin, P. J., Chen, T. C. & Ou, J. T. (1998). Frequency of Epstein–Barr virus-associated gastric adenocarcinoma in Taiwan. Cancer Lett 129: 125–129.
IARC Working Group (1994). Monographs on the evaluation of the carcinogenic risks to humans: schistosomes, liver flukes and. Helicobacter pylori, IARC 61: 177–241.
Kikuchi, S., Wada, O., Nakajima, T., Nishi, T., Kobayashi, O., Konishi, T. & Inaba, Y. (1995). Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Cancer 75: 2789–2793.
Kuipers, E. J., Uyterlinde, A. M., Pena, A. S., Roosendaal, R., Pais, G., Nelis, G. F., Festen, H. P. M. & Meuwissen, S. G. M. (1995). Long-term sequelae of Helicobacter pylori gastritis. Lancet 345: 1525–1528.
Michetti, P., Wadstrom, T., Kraehenbuhl, J. P., Lee, A., Kreiss, C. & Blum, A. L. (1996). Frontiers in Helicobacter pylori research: pathogenesis, host response, vaccine development and new therapeutic approaches. Eur J Gastroenterol Hepatol 8: 717–722.
Murray, C. J. L. & Lopez, A. D. (1997). Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349: 1498–1504.
Parsonnet, J., Vandersteen, D., Goates, J., Sibley, R. K., Pritikin, J. & Chang, Y. (1991). Helicobacter pylori infection in intestinal- and diffuse-type adenocarcinomas. J Natl Cancer Inst 83: 640–643.
Parsonnet, J., Harris, R. A., Hack, H. M. & Owens, D. K. (1996). Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 348: 150–154.
Peto, R. (1990). General reflections on principles and purposes: indirect and direct purposes of the present monograph. In Diet, Lifestyle and Mortality in China: A Study of the Characteristics of 65 Chinese Counties, Junshi C, Campbell TC, Junyao L and Peto R (eds), pp. 72–78. Diet, Lifestyle and Mortality in China: A Study of the Characteristics of 65 Chinese Counties. Oxford University Press: Oxford
Sakaki, N., Momma, K., Egawa, N., Yamada, Y., Kan, T. & Ishiwata, J. (1995). The Influence of Helicobacter pylori infection on the progression of gastric mucosal atrophy and occurrence of gastric cancer. Eur J Gastroenterol Hepatol 7: S59–S62.
Sonnenberg, A. & Inadomi, J. M. (1998). Review article: Medical decision models of Helicobacter pylori therapy to prevent gastric cancer. Aliment Pharm Ther 12: 111–121.
Swerdlow, A. J., Dos Santos Silva, I., Reid, A., Qiao, Z., Brewster, D. H. & Arrundale, J. (1998). Trends in cancer incidence and mortality in Scotland. Br J Cancer 77: 1–16.
Watanabe, T., Tada, M., Nagai, H., Sasaki, S. & Nakao, M. (1998). Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 115: 642–648.
Webb, P. M. & Forman, D. (1996). Helicobacter pylori as a risk factor for cancer. Baillière’s Clin Gastroenterol 9: 563–582.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Danesh, J. Helicobacter pyloriand gastric cancer: time for mega-trials?. Br J Cancer 80, 927–929 (1999). https://doi.org/10.1038/sj.bjc.6690444
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690444
